Form 4 for MNPR Monopar Therapeutics
Accepted 2025-10-02 00:00:00 ET · period of report 2025-09-30 · accession 0001437749-25-030284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-02 | 2025-09-30 | MNPR | Robinson Chandler | CEO, Dir | M - OptEx | — | +8,726 | 82.2K | +12% | — |
| D | 2025-10-02 | 2025-09-30 | MNPR | Robinson Chandler | CEO, Dir | F - Tax | $81.67 | -2,646 | 79.6K | -3% | -$216.1K |
| D | 2025-10-02 | 2025-09-30 | MNPR | Robinson Chandler | CEO, Dir | M - OptEx | $0.00 | -8,726 | 72.6K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-30 | M | A | 8,726 | — | 82,198 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Common | Common Stock | 2025-09-30 | F | D | 2,646 | $81.67 | 79,552 | D | — | — | (F2) Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-09-30 | M | D | 8,726 | $0.00 | 72,599 | D | — · — to — | 8,726 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F6) On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. (F4) On February 2, 2022, the reporting person was granted 31,905 restricted stock units, vesting 6/48ths (3,988 shares) on June 30, 2022, and 3/48ths (1,994 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. (F5) On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |